Revolutionizing Regenerative Medicine with Scalable Stem Cell Technology
Pioneering the SIST™ platform to deliver high yield adult stem cells for breakthrough therapies and advanced aesthetics
Discover Chiron Therapeutics
Watch our company overview to learn about our revolutionary stem cell technology
and our mission to transform regenerative medicine, beauty & healing.
Company Overview
Learn about our mission, technology, and vision for the future of regenerative medicine, beauty & healing.
- Innovative Technology: Our SIST technology revolutionizes stem cell therapy delivery
- Highly Promising Results: Preclinical findings indicate strong cosmetic and therapeutic potential
- Expert Team: Leading scientists and researchers driving innovation
A Robust Pipeline of Stem Cell Therapies & Aesthetics
Our cutting-edge Suspension-Induced Stem Cell Transition (SIST) technology delivers a remarkable 100X increase in ASC yield, offering a highly scalable and safe solution for treating many diseases.
Innovating Skin Rejuvenation with Stem Cell-Derived Exosomes
At Chiron Therapeutics, we are pioneering a new era in skincare and skin rejuvenation through stem cell-derived exosomes.
Cartilage Regeneration Therapy
Our innovative, patented method generates functional chondrocytes—specialized cartilage-producing cells—from readily accessible somatic skin cells, eliminating the need for invasive bone marrow procedures.
Wound Healing Therapy
Our scalable, patient-friendly method meets the growing need for generating human keratinocyte stem cells, which are essential for effective wound repair and skin regeneration.
KEY ADVANTAGES
Our Technology Edge
Our proprietary Suspension-Induced Stem Cell Transition (SIST) technology offers significant advantages over traditional stem cell therapy approaches.
High-Yield and Scalable
Our scalable process enables high-volume stem cell production for clinical therapies and cosmetic formulations.
Safety First
Our technology bypasses the need of exogenous transgenes or viral vectors, negating the risk of viral genome integration, genetic instability and tumorigenesis.
Tissue Specificity
Our method generates adult stem cells (ASCs) tailored to specific tissue types, enhancing their therapeutic relevance for targeted regenerative treatments.
Send Us A Message
We’re here to answer your questions and help you get started.
We'd Love To Hear From You
Have questions about our stem cell therapies or interested in potential collaborations? We're here to help and eager to explore possibilities together.
